XEN496

ezogabine · Xenon Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XEN496, covering 2024-08-23 to 2024-08-23. Get the full timeline:

Most recent: Clinical Trial Update: XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy [Phase 3]